This company has been marked as potentially delisted and may not be actively trading. Akoya Biosciences (AKYA) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Get the Latest News and Ratings for AKYA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Akoya Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AKYA Analyst Ratings Over TimeTypeCurrent Forecast8/29/24 to 8/29/251 Month Ago7/30/24 to 7/30/253 Months Ago5/31/24 to 5/31/251 Year Ago8/30/23 to 8/29/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)5 Buy rating(s)Hold4 Hold rating(s)7 Hold rating(s)7 Hold rating(s)4 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$2.38$2.51$2.51$6.56Forecasted Upside84.69% Upside94.26% Upside102.91% Upside148.58% UpsideConsensus RatingHoldHoldHoldModerate Buy AKYA Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History AKYA Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Akoya Biosciences Stock vs. The CompetitionTypeAkoya BiosciencesMedical CompaniesS&P 500Consensus Rating Score 2.00 2.78 2.53Consensus RatingHoldModerate BuyModerate BuyPredicted Upside84.69% Upside16,036.22% Upside9.98% UpsideNews Sentiment RatingNeutral NewsSee Recent AKYA NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails5/19/2025Canaccord Genuity Group2 of 5 starsK. MiksonSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetHold ➝ Hold$1.80 ➝ $1.08+6.40%4/14/2025Piper Sandler2 of 5 starsDavid WestenbergSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetNeutral ➝ Neutral$2.40 ➝ $1.65+34.15%3/25/2025Stephens4 of 5 starsMason CarricoSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Equal Weight$3.50 ➝ $1.80+11.46%11/15/2024Craig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingB. BonelloSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$7.00 ➝ $5.00+59.74%8/6/2024Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOverweight ➝ Equal Weight$4.00 ➝ $3.00+50.00%8/6/2024BTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. MassaroSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral8/6/2024JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOverweight ➝ Neutral3/5/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$7.00 ➝ $7.50+40.71%12/14/2023GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageNeutralAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 04:00 PM ET. AKYA Forecast - Frequently Asked Questions What is Akoya Biosciences' forecast for 2025? According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Akoya Biosciences is $2.38, with a high forecast of $5.00 and a low forecast of $1.08. Should I buy or sell Akoya Biosciences stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akoya Biosciences in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AKYA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AKYA, but not buy additional shares or sell existing shares. Does Akoya Biosciences's stock price have much upside? According to analysts, Akoya Biosciences's stock has a predicted upside of 84.69% based on their 12-month stock forecasts. Do Wall Street analysts like Akoya Biosciences more than its competitors? Analysts like Akoya Biosciences less than other "medical" companies. The consensus rating for Akoya Biosciences is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AKYA compares to other companies. Stock Forecasts and Research Tools Related Companies Quantum-Si Stock Forecast 908 Devices Stock Forecast Quanterix Stock Forecast Owlet Stock Forecast Rapid Micro Biosystems Stock Forecast Prenetics Global Stock Forecast Nautilus Biotechnology Stock Forecast inTEST Stock Forecast Odysight.ai Stock Forecast ClearSign Technologies Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:AKYA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access